Zacks: Brokerages Expect CME Group Inc (CME) Will Announce Quarterly Sales of $1.02 Billion

Equities research analysts expect CME Group Inc (NASDAQ:CME) to report sales of $1.02 billion for the current quarter, according to Zacks. Three analysts have provided estimates for CME Group’s earnings, with the highest sales estimate coming in at $1.03 billion and the lowest estimate coming in at $993.30 million. CME Group posted sales of $900.00 million in the same quarter last year, which would indicate a positive year over year growth rate of 13.3%. The firm is scheduled to report its next earnings report on Thursday, February 7th.

According to Zacks, analysts expect that CME Group will report full year sales of $4.03 billion for the current fiscal year, with estimates ranging from $3.86 billion to $4.10 billion. For the next financial year, analysts forecast that the business will report sales of $4.53 billion, with estimates ranging from $4.03 billion to $5.05 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for CME Group.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Thursday, October 25th. The financial services provider reported $1.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.03. CME Group had a net margin of 113.67% and a return on equity of 9.18%. The company had revenue of $904.20 million for the quarter, compared to analyst estimates of $910.50 million.

CME has been the topic of several recent research reports. BidaskClub lowered shares of CME Group from a “buy” rating to a “hold” rating in a research report on Friday, July 27th. Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating in a research report on Wednesday, August 22nd. Jefferies Financial Group reiterated a “buy” rating and set a $190.00 target price on shares of CME Group in a research report on Wednesday, September 5th. Rosenblatt Securities initiated coverage on shares of CME Group in a research report on Wednesday, September 5th. They set a “neutral” rating and a $177.00 target price on the stock. Finally, Berenberg Bank set a $184.00 target price on shares of CME Group and gave the company a “hold” rating in a research report on Thursday, September 20th. Four investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $190.23.

In related news, Director Jeffrey M. Bernacchi sold 4,976 shares of CME Group stock in a transaction dated Tuesday, September 4th. The shares were sold at an average price of $176.60, for a total transaction of $878,761.60. Following the completion of the transaction, the director now directly owns 52,004 shares of the company’s stock, valued at approximately $9,183,906.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Hilda Harris Piell sold 1,823 shares of CME Group stock in a transaction dated Tuesday, September 4th. The shares were sold at an average price of $175.00, for a total transaction of $319,025.00. Following the transaction, the insider now directly owns 30,176 shares of the company’s stock, valued at $5,280,800. The disclosure for this sale can be found here. Insiders have sold a total of 29,419 shares of company stock valued at $5,346,532 over the last three months. 0.43% of the stock is currently owned by insiders.

Several hedge funds and other institutional investors have recently made changes to their positions in the business. BlackRock Inc. raised its stake in shares of CME Group by 1.8% in the third quarter. BlackRock Inc. now owns 22,422,112 shares of the financial services provider’s stock worth $3,816,468,000 after acquiring an additional 403,327 shares during the last quarter. Capital International Investors raised its stake in shares of CME Group by 18.3% in the third quarter. Capital International Investors now owns 15,425,378 shares of the financial services provider’s stock worth $2,625,554,000 after acquiring an additional 2,383,280 shares during the last quarter. Capital Research Global Investors raised its stake in shares of CME Group by 107.8% in the third quarter. Capital Research Global Investors now owns 10,906,683 shares of the financial services provider’s stock worth $1,856,427,000 after acquiring an additional 5,658,108 shares during the last quarter. Edgewood Management LLC raised its stake in shares of CME Group by 9.5% in the third quarter. Edgewood Management LLC now owns 8,582,518 shares of the financial services provider’s stock worth $1,460,830,000 after acquiring an additional 742,067 shares during the last quarter. Finally, Janus Henderson Group PLC raised its stake in shares of CME Group by 3.3% in the third quarter. Janus Henderson Group PLC now owns 6,331,522 shares of the financial services provider’s stock worth $1,077,689,000 after acquiring an additional 202,365 shares during the last quarter. 84.55% of the stock is owned by institutional investors.

Shares of CME Group stock traded down $2.15 during trading on Thursday, hitting $190.01. 1,833,990 shares of the company’s stock traded hands, compared to its average volume of 2,554,592. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.09 and a current ratio of 1.09. CME Group has a twelve month low of $140.51 and a twelve month high of $197.08. The firm has a market cap of $65.31 billion, a P/E ratio of 39.83, a price-to-earnings-growth ratio of 2.23 and a beta of 0.49.

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 27th. Investors of record on Monday, December 10th will be issued a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a yield of 1.47%. The ex-dividend date of this dividend is Friday, December 7th. CME Group’s dividend payout ratio is currently 58.70%.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Featured Story: What Is An Exchange-Traded Fund (ETF)?

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply